Are you Dr. Durkee-Shock?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 18 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Bethesda, MD 20892Phone+1 301-272-0628
Summary
- Dr. Jessica Durkee-Shock, MD is a board certified pediatrician in Bethesda, Maryland. She is currently licensed to practice medicine in District of Columbia, Rhode Island, and Massachusetts.
Education & Training
- University of MarylandResidency, Internal Medicine, 2013 - 2016
- University of MarylandResidency, Internal Medicine/Pediatrics, 2013 - 2016
- University of Maryland School of MedicineClass of 2012
Certifications & Licensure
- DC State Medical License 2018 - 2024
- RI State Medical License 2017 - 2018
- MA State Medical License 2016 - 2017
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- A Decade of Chronic Norovirus Infection Surveillance at the NIH Clinical Research Center: Clinical Characteristics, Molecular Epidemiology, and Replication.Natthawan Chaimongkol, Daniel Y Kim, Yuki Matsushima, Jessica Durkee-Shock, Karenna Barton
The Journal of Infectious Diseases. 2024-08-29 - Reconstitution of norovirus-specific T cell responses following hematopoietic stem cell transplantation in patients with inborn errors of immunity and chronic noroviru...Jessica Durkee-Shock, Ariella Cohen, Naseem Maghzian, Gloria Pezzella, Mariah Jensen-Wachspress
The Journal of Infectious Diseases. 2024-08-14 - 15 citationsImmunizing the imperfect immune system: Coronavirus disease 2019 vaccination in patients with inborn errors of immunity.Jessica R Durkee-Shock, Michael D Keller
Annals of Allergy, Asthma & Immunology. 2022-11-01
Press Mentions
- As Links to MS Deepen, Researchers Accelerate Efforts to Develop an Epstein-Barr VaccineOctober 19th, 2022
- SARS-CoV-2-Specific T-cell Responses Are Amplified in Children with Multisystem Inflammatory Syndrome in ChildrenAugust 27th, 2021